0 13 Non-steroidal non-steroidal JJ 14 31 anti-inflammatory anti-inflammatory JJ 32 37 drugs drug NNS 38 45 inhibit inhibit VBP 46 49 the the DT 50 60 expression expression NN 61 63 of of IN 64 73 cytokines cytokine NNS 74 77 and and CC 78 84 induce induce VB 85 90 HSP70 hsp70 NN 91 93 in in IN 94 99 human human JJ 100 109 monocytes monocyte NNS 109 110 . . . 112 118 Recent recent JJ 119 126 studies study NNS 127 131 have have VBP 132 137 shown show VBN 138 142 that that IN 143 146 the the DT 147 160 non-steroidal non-steroidal JJ 161 178 anti-inflammatory anti-inflammatory JJ 179 184 drugs drug NNS 185 186 ( ( ( 186 192 NSAIDs NSAID NNPS 192 193 ) ) ) 194 202 activate activate VBP 203 207 heat heat NN 208 213 shock shock NN 214 227 transcription transcription NN 228 234 factor factor NN 235 236 ( ( ( 236 240 HSF1 HSF1 NNP 240 241 ) ) ) 242 246 from from IN 247 248 a a DT 249 255 latent latent JJ 256 267 cytoplasmic cytoplasmic JJ 268 272 form form NN 273 275 to to TO 276 277 a a DT 278 285 nuclear nuclear JJ 285 286 , , , 287 290 DNA DNA NNP 291 298 binding binding NN 299 304 state state NN 304 305 . . . 306 308 As as IN 309 313 HSF1 HSF1 NNP 314 317 can can MD 318 326 function function VB 327 329 as as IN 330 334 both both CC 335 337 an an DT 338 347 activator activator NN 348 350 of of IN 351 355 heat heat NN 356 361 shock shock NN 362 367 genes gene NNS 368 371 and and CC 372 373 a a DT 374 383 repressor repressor NN 384 386 of of IN 387 395 non-heat non-heat JJ 396 401 shock shock NN 402 407 genes gene NNS 408 412 such such JJ 413 415 as as IN 416 420 IL1B IL1B NNP 421 424 and and CC 425 427 c- c- NN 428 431 fos fo NNS 431 432 , , , 433 435 we we PRP 436 440 have have VBP 441 449 examined examine VBN 450 453 the the DT 454 463 potential potential JJ 464 468 role role NN 469 471 of of IN 472 476 HSF1 hsf1 NN 477 479 in in IN 480 483 the the DT 484 491 effects effect NNS 492 494 of of IN 495 501 NSAIDs nsaid NNS 502 504 on on IN 505 509 gene gene NN 510 520 expression expression NN 521 523 in in IN 524 525 a a DT 526 531 human human JJ 532 541 monocytic monocytic JJ 542 546 cell cell NN 547 551 line line NN 552 557 THP-1 thp-1 NN 557 558 . . . 559 561 We we PRP 562 567 found find VBD 568 572 that that IN 573 576 two two CD 577 584 members member NNS 585 587 of of IN 588 591 the the DT 592 598 NSAIDs NSAID NNP 598 599 , , , 600 606 sodium sodium NN 607 617 salicylate salicylate NN 618 621 and and CC 622 630 sulindac sulindac NN 631 638 repress repress VBP 639 642 the the DT 643 647 IL1B il1b NN 648 656 promoter promoter NN 657 659 to to TO 660 667 similar similar JJ 668 674 degree degree NN 675 677 to to TO 678 682 heat heat NN 683 688 shock shock NN 689 691 or or CC 692 696 HSF1 hsf1 NN 697 711 overexpression overexpression NN 711 712 . . . 713 715 In in IN 716 724 addition addition NN 724 725 , , , 726 732 sodium sodium NN 733 743 salicylate salicylate NN 744 747 and and CC 748 758 additional additional JJ 759 765 NSAIDs nsaid NNS 766 770 used use VBN 771 773 at at IN 774 788 concentrations concentration NNS 789 793 that that WDT 794 802 activate activate VBP 803 807 HSF1 hsf1 NN 808 812 also also RB 813 822 inhibited inhibit VBD 823 826 the the DT 827 837 expression expression NN 838 840 of of IN 841 846 other other JJ 847 856 monocytic monocytic JJ 857 862 genes gene NNS 863 864 ( ( ( 864 873 TNF-alpha TNF-alpha NNP 873 874 , , , 875 883 IL-1beta IL-1beta NNP 883 884 , , , 885 889 IL-6 IL-6 NNP 889 890 , , , 891 895 IL-8 IL-8 NNP 895 896 , , , 897 902 IL-10 IL-10 NNP 902 903 , , , 904 910 ICAM-1 ICAM-1 NNP 910 911 ) ) ) 912 921 activated activate VBN 922 924 by by IN 925 933 exposure exposure NN 934 936 to to TO 937 938 a a DT 939 955 pro-inflammatory pro-inflammatory JJ 956 964 stimulus stimulus NN 965 966 ( ( ( 966 984 lipopolysaccharide lipopolysaccharide NN 984 985 , , , 986 989 LPS LPS NNP 989 990 ) ) ) 990 991 . . . 992 994 At at IN 995 1000 least least JJS 1001 1003 in in IN 1004 1007 the the DT 1008 1012 case case NN 1013 1015 of of IN 1016 1019 the the DT 1020 1024 IL1B IL1B NNP 1025 1033 promoter promoter NN 1033 1034 , , , 1035 1045 repression repression NN 1046 1049 did do VBD 1050 1053 not not RB 1054 1058 seem seem VB 1059 1061 to to TO 1062 1069 involve involve VB 1070 1077 another another DT 1078 1084 factor factor NN 1085 1090 whose whose WP$ 1091 1099 activity activity NN 1100 1102 is be VBZ 1103 1111 affected affect VBN 1112 1114 by by IN 1115 1118 the the DT 1119 1125 NSAIDs NSAID NNP 1125 1126 , , , 1127 1135 NFkappaB NFkappaB NNP 1136 1138 as as IN 1139 1142 the the DT 1143 1147 IL1B IL1B NNP 1148 1156 promoter promoter NN 1157 1165 fragment fragment NN 1166 1170 used use VBN 1171 1173 in in IN 1174 1177 our our PRP$ 1178 1185 studies study NNS 1186 1188 is be VBZ 1189 1192 not not RB 1193 1201 NFkappaB nfkappab NN 1202 1212 responsive responsive JJ 1213 1216 and and CC 1217 1222 binds bind VBZ 1223 1235 specifically specifically RB 1236 1238 to to TO 1239 1243 HSF1 hsf1 NN 1243 1244 . . . 1245 1253 Exposure exposure NN 1254 1256 to to TO 1257 1263 NSAIDs NSAID NNP 1264 1267 had have VBD 1268 1269 a a DT 1270 1277 complex complex JJ 1278 1284 effect effect NN 1285 1287 on on IN 1288 1291 HSP HSP NNP 1292 1296 gene gene NN 1297 1307 expression expression NN 1308 1311 and and CC 1312 1317 while while IN 1318 1326 sulindac sulindac NN 1327 1336 activated activate VBD 1337 1340 the the DT 1341 1347 stress stress NN 1348 1358 responsive responsive JJ 1359 1365 HSP70B HSP70B NNP 1366 1374 promoter promoter NN 1374 1375 , , , 1376 1382 sodium sodium NN 1383 1393 salicylate salicylate NN 1394 1397 did do VBD 1398 1401 not not RB 1401 1402 . . . 1403 1405 In in IN 1406 1414 addition addition NN 1414 1415 , , , 1416 1420 only only RB 1421 1422 a a DT 1423 1429 subset subset NN 1430 1432 of of IN 1433 1436 the the DT 1437 1443 NSAIDs NSAID NNPS 1444 1451 induced induce VBD 1452 1457 HSP70 HSP70 NNP 1458 1462 mRNA mrna NN 1463 1470 species specie NNS 1470 1471 . . . 1472 1477 These these DT 1478 1486 findings finding NNS 1487 1494 reflect reflect VBP 1495 1498 the the DT 1499 1509 properties property NNS 1510 1512 of of IN 1513 1517 HSF1 hsf1 NN 1518 1523 which which WDT 1524 1527 can can MD 1528 1530 be be VB 1531 1540 activated activate VBN 1541 1543 to to TO 1544 1546 at at IN 1547 1552 least least JJS 1553 1556 two two CD 1557 1560 DNA dna NN 1561 1568 binding binding NN 1569 1574 forms form NNS 1575 1579 only only RB 1580 1583 one one CD 1584 1586 of of IN 1587 1592 which which WDT 1593 1602 activates activate VBZ 1603 1607 heat heat NN 1608 1613 shock shock NN 1614 1623 promoters promoter NNS 1624 1627 and and CC 1628 1635 suggest suggest VBP 1636 1640 that that IN 1641 1651 individual individual JJ 1652 1657 NSAID nsaid NN 1658 1664 family family NN 1665 1672 members member NNS 1673 1676 may may MD 1677 1691 differentially differentially RB 1692 1698 induce induce VB 1699 1702 one one CD 1703 1705 or or CC 1706 1711 other other JJ 1712 1714 of of IN 1715 1720 these these DT 1721 1726 forms form NNS 1726 1727 . . . 1728 1735 Overall overall RB 1736 1745 therefore therefore RB 1745 1746 , , , 1747 1755 exposure exposure NN 1756 1758 to to TO 1759 1765 NSAIDs NSAID NNP 1766 1771 leads lead VBZ 1772 1774 to to TO 1775 1776 a a DT 1777 1785 profound profound JJ 1786 1792 switch switch NN 1793 1795 in in IN 1796 1800 gene gene NN 1801 1811 expression expression NN 1812 1814 in in IN 1815 1824 monocytic monocytic JJ 1825 1830 cells cell NNS 1830 1831 , , , 1832 1836 with with IN 1837 1848 suppression suppression NN 1849 1851 of of IN 1852 1857 genes gene NNS 1858 1866 involved involve VBN 1867 1869 in in IN 1870 1880 macrophage macrophage NN 1881 1891 activation activation NN 1892 1895 and and CC 1896 1905 induction induction NN 1906 1908 of of IN 1909 1915 stress stress NN 1916 1921 genes gene NNS 1922 1925 and and CC 1926 1930 HSF1 hsf1 NN 1931 1938 appears appear VBZ 1939 1941 to to TO 1942 1946 play play VB 1947 1948 a a DT 1949 1959 regulatory regulatory JJ 1960 1964 role role NN 1965 1967 in in IN 1968 1973 these these DT 1974 1981 effects effect NNS 1981 1982 . . . 1983 1992 Copyright Copyright NNP 1993 1997 1999 1999 CD 1998 2006 Academic Academic NNP 2007 2012 Press Press NNP 2012 2013 . . .